Rocket Pharmaceuticals received FDA accelerated approval for Kresladi, validating its gene therapy platform. Find out why RCKT stock is a hold.

Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta ...

Boston Scientific (NYSE:BSX) executives highlighted new data from two randomized clinical trials during an American College of Cardiology conference call, describing the results as potentially ...

BridgeBio Pharma has announced that long-term efficacy and safety data from the open-label extension of its Phase 3 ATTRibute-CM trial of transthyretin stabilizer acoramidis in ATTR-CM, along with ...

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated ...

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from ...

For the first time since 2018, a clinical guideline from the American College of Cardiology and the American Heart Association for screening and managing blood cholesterol levels has been updated and ...

The initiative has been developed by the World Health Organisation Collaborating Centre for Traditional Medicine (Yoga) (WHOCCIND 118), at the Morarji Desai National Institute of Yoga under the ...

UMass Lowell researchers have uncovered an innovative way to spot Alzheimer’s disease long before an official diagnosis.

The highly-mutated variant could evade vaccine immunity due to spike protein mutations.

The steep rise in kratom-related calls and serious medical outcomes have underscored a rapidly changing market.

AI and digital labs are transforming how diseases are detected in India but can they solve delays, specialist shortages and rising chronic illnesses? Experts explain what this shift means for patients ...